MedTrace Logo

The ITA Model of Integrated Treatment of Eating Disorders

NCT04127214 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-04-01

No results posted yet for this study

Summary

This is a naturalistic study implementing a routine assessment to monitor the evolution of the patients with eating disorders being treated in various centers of "ITA salud mental" in Spain.

Conditions

  • Eating Disorders
  • Anorexia Nervosa
  • Bulimia Nervosa
  • Binge Eating
  • Eating Disorders in Adolescence
  • Eating and Feeding Disorders

Interventions

OTHER

ITA Integrated Treatment

The ITA Model combines outpatient intervention (mainly psychotherapy), day hospital care and hospitalization as a function of patients' characteristics. Case conceptualization of the psychological processes of patients is formulated and revised within a team including psychologists, psychotherapists, psychiatrists, nutritionists, physicians, nurses, and social workers. The major emphasis of the ITA model is on psychological interventions which include individual psychotherapy, family therapy and/or guidance, and group therapy of various formats and contents (e.g., drug abuse, mindfulness, emotion work) tailored to the needs of each patient. However, when required, drugs are prescribed adjusting type of medication and dosage to the need of the patient.

Sponsors & Collaborators

  • ITA salud mental

    collaborator UNKNOWN

  • University of Barcelona

    lead OTHER

Principal Investigators

  • Guillem Feixas, PhD · Universitat de Barcelona, Spain

  • Antoni Grau-Touriño, Psychologist · ITA salud mental, Spain

  • Chris Evans, MD · University of Sheffield, UK

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-02
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04127214 on ClinicalTrials.gov